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Background: Human peripheral blood mononuclear
cells  (PBMC)  left  in  microcultures  for  24 h  without
mitogen  do  not  respond  to  subsequent  stimulation
with PHA. They regain reactivity if the native culture
medium is absorbed with other party lymphocytes or
partially  replaced  with  the  medium  from  a  PHA-
stimulated  culture.  The  observations  suggest  that,
during  the  incubation,  some  inhibitory  agent  had
accumulated in the culture medium.
Aim:  The  study  was  performed  to  determine  the
nature of the observed phenomenon in respect of the
possible  role  of monocytes  and  their  products  IL-1
and IL-1 receptor antagonist (IL-1ra), and to test for
immunodiagnostic purposes the significance of quan-
tifying the lymphocyte response to delayed stimula-
tion with PHA in patients suffering from inflamma-
tory prosesses.
Methods:  Lymphocyte  response to  delayed  stimula-
tion with PHA, calculated as the lymphocyteÐmono-
kine interaction (LM) index, was determined in the
microcultures  of  PBMC  isolated  from  the  blood  of
healthy  donors  or  of  patients  with  acute  tonsilitis.
The  values  of  LM  indices  were  compared  with  the
ratios  of  IL-1ra/IL-1b concentration  estimated  by
enzyme-linked immunosorbent assay method in the
culture supernatants. The influences of exogenous IL-
1b ,  IL-1ra, anti-IL1ra  antibodies and antibiotic  cefa-
clor  on  the  monokine  concentrations  and  on  the
values of LM index were tested.
Results  and conclusions:  The results  show that  the
level of lymphocyte response to delayed stimulation
with PHA (LM index) is inversely proportional to the
ratio of IL-1ra/IL-1b concentration in the culture. The
low  LM  values  at  high  IL-1ra/IL-1b ratios  in  PBMC
cultures from healthy donors, reversed proportions
found  in  patients’  PBMC  (acute  tonsilitis),  and  the
cefaclor-induced  reduction  of  LM  value  with  corre-
lated increase of the IL-1ra/IL-1b ratio suggest that the
LM  assay  may  prove  to  be  useful  for  immunodiag-
nostic purposes.
Key  words:  IL-1b and  IL-1ra  competition,  Delayed
response to mitogen, LM assay – prognostic significance?
Introduction
Phagocytosis, digestive processing, and presentation
of antigen in complexes with self-histocompatibility
molecules,  supported  by  expression  of  additional
immunogenic  signals  (including  monokines, prosta-
glandins  and  oxidative  radicals),  collectively  deter-
mine  the  participation of  monocytes  in  the  induc-
tion  of  specific  immune  responses  and  their
concomitant  contribution  to  development  and
maintenance  of  immunogenic  tissue  inflammation.
One  of  the  most  potent  immuno-enhancing  mem-
bers  of  the  monokine  family  is  interleukin-1.1,2 To
exert  its  immunostimulatory  and  pro-inflammatory
effects,  IL-1 has to  compete with  the  other mono-
cyte  product,  monokine  IL-1  receptor  antagonist
(IL-1ra), for access to its receptors on the surface of
the  target  cell.  In  contrast to  IL-1,  IL-1ra  is  unable
to transduce the stimulatory signal; thus, in binding
to  the  receptor,  the  IL-1ra  prevents  its
activation.3–5
Assessments of alterations in the IL-1ra/IL-1 concen-
tration  ratio  within  the  humoral  environment  of
responding  cells  may  provide  clinically  important
information  on  the  stage  of  the  ongoing  immune
response and on the progression of the inflammatory
process. In general, the lower values of the IL-1ra/IL-1
ratio characterise the developmental phase, whereas
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The  IL-1ra/IL-1  concentration ratio  is  measurable
close  to  responding  cells  (in  inflammatory  tissue
fluids)  or  at  distant  humoral  peripheries  (blood
serum,  spinal  cord  fluid,  urine  samples).  In  this
respect, testing sites in the closest humoral vicinity
can be expected to yield the most accurate informa-
tion  on  the  actual  functional  state  of  a  cellular
source  of  assessed monokines.  Moreover,  this  goal
may  be  gained  by  direct  measurements  of  respec-
tive monokine concentrations (enzyme-linked immu-
nosorbent assay  (ELISA)  method), or  by  estimation
of  the  behaviour  of  other  cells  that  are  natural
neighbours of monocytes and are primarily depend-
ent on their monokine influence (e.g. the mitogenic
proliferative response of T lymphocytes).
The  mononuclear  cell  population  isolated  from
peripheral blood and set-up in culture contains the
quantity of monocytes and T cells representative of
their  respective  blood  values.  Under  appropriate
experimental  conditions,  the  results  of  tests  per-
formed on the cultures offer a possibility to obtain
in  vitro insight  into  the  actual  functional  state  of
immune  cells’ in vivo,  characteristic for the tested
individual.
Other  authors and  ourselves10,11 have previously
observed  that  human  blood-derived  mononuclear
cells, if incubated in microcultures for 24h without
mitogenic  stimulation,  lose  the  capacity  for  pro-
liferative  response  to  subsequent  stimulation  with
PHA,  as  can  be  demonstrated at  72h  by  measure-
ment of [3H]-thymidine incorporation. Although the
number and viability of cells remained undisturbed,
any  trials,  including  changes  of  PHA  concentration
(from suboptimal to overoptimal doses) or addition
of  exogenous  IL-2,  did  not  induce  the  proliferative
response.  Nevertheless,  the  cells  could  regain  the
reactivity  if  their  native  culture  medium  was  par-
tially  replaced  at  24h  with  the  cell-free  medium
from  a  PHA-stimulated  culture  or  if  part  of  it  was
separately  absorbed  with  autologous  lymphocytes
and returned to the original cell culture before the
stimulation.
These  observations  suggested  that  some  inhibi-
tory  humoral  agent  had  accumulated  in  culture
medium during the 24h of incubation, and that the
level  of  lymphocyte  reactivity  regained  upon  sub-
sequent  stimulation with PHA is dependent on the
concentration of the putative inhibitory agent.
The  aim  of  the  present  experiments  was  to
determine the nature of the observed phenomenon
in  respect  of  the  possible  role  of  monocytes  and
their  products,  IL-1  and  IL-1ra,  and  to  test  for
immunodiagnostic  purposes  the  significance  of
quantifying  the  lymphocyte  response  to  delayed
stimulation  with  PHA  in  patients  suffering  from
inflammatory processes.
Materials and methods
Peripheral  blood  mononuclear  cells  (PBMC)  were
isolated  by  density  gradient  sedimentation  (Ficol/
Hypaque,  1.007g/ml,  Pharmacia  LKB,  Uppsala,
Sweden) of heparinised venous blood samples taken
from healthy donors or patients suffering from acute
infections of the upper respiratory tract (both sexes,
age range 20–40 years). After determination of  cell
viability, the microcultures were set-up in triplicate in
Nuncoln  round-bottomed  96-well  microplates,  as
previously  described.10 In  brief,  the  cultures  (each
containing 105 cells in 0.2ml of RPMI 1640 supple-
mented with 15%  of inactivated autologous serum)
were incubated at 37°C in an ASSAB incubator in a
humified atmosphere of 5% CO2 in  air for 72h. In
each  experiment,  several  sets  of  triplicate  micro-
cultures  were  left  without  stimulation  and  others
were  stimulated  at  0h  with  PHA  (HA16,
0.4 m g/culture,  optimal  dose;  Murex  Biotech  Ltd.,
Dartford,  UK).  For  the  last  16h  of  incubation,
[3H]-thymidine  (3HTdR)  (specific  activity,  5Ci/mM;
Amersham, UK) was added into the cultures in a dose
of 0.4 m Ci per well. After harvesting the cultures, the
measurements  of  incorporated  radioactivity  were
carried  out  in  a  Tri-carb  2100  TR  Packard  liquid
scintillation analyser and the results were expressed
as a mean value of disintegrations per minute (dpm) ±
SD  for  each triplicate. Additionally,  the  volumes  of
0.1ml  of  cell-free  medium  (CFM)  were removed at
24h from separate sets of triplicated non-stimulated
cultures  and  replaced  with  equal  volumes  of  CFM
taken  from  PHA-stimulated  cultures.  The  cultures
rearranged  on  this  way  were  further  processed  as
already  described and served for  calculation of LM
indices according to the formula:
LM index = 
mean value of dpm in rearranged cultures
mean value of dpm in non-stimulated cultures
We have decided to use this formula for the following
reasons. The sparse cells in the PBMC population that
‘spontaneously’  incorporate  3HTdR  in  vitro have
already entered in vivo the S phase of cell cycle and
they do not participate in the response of other cells
to the subsequent stimulation with mitogen. Under
these circumstances,  the  simple  subtraction  of  the
values  of  radioactivity  incorporated  by  the  cells
stimulated in entirely different ways does not seem to
be  well  justified.  On  the  contrary,  the  ratio  of
mitogen-stimulated  to  ‘spontaneous’  incorporation
seems to provide adequate information on how many
more  cells  have  contributed  to  the  observed  total
value of incorporated radioactivity.
Concomitantly,  the  samples  of  CFM  removed  at
24h  from  non-stimulated  cultures  were  frozen  and
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1b and IL-1ra content. The assessments were carried
out  in  the  universal  microplate  analyzer  Elx800
(Biokom,  Poland)  with  application  of  respective
Quantikine kits (R&D Systems, Abingdon, UK).
In one particular experiment, the combined CFM
collected at  24h  from  two  sets  of  triplicated non-
stimulated cultures (0.6ml in total) was absorbed for
30min  with 106 autologous lymphocytes and, after
centrifugation, returned at 0.1ml per culture into one
set  of  the  original  triplicated  cultures. These  were
then stimulated with PHA and further processed as
already described.
In consecutive experiments, separate sets of tripli-
cated microcultures were treated at 0h with 20ng/ml
recombinant  human  IL-1b (Genzyme,  Cambridge,
MA, USA), 20ng/ml recombinant human IL-1ra (Sero-
tec, Oxford, UK), 5 m g/ml anti-human IL-1ra neutral-
ising  antibody  (lot  number  Z05;  R&D  Systems),  or
with 40 m g/ml pure soluble substance of cefaclor (Elli
Lilly, Poland). These cultures were further processed
as already described to assess the IL-1ra/IL-1b concen-
tration ratio and/or the LM index.
The  results  were  statistically  analysed  using  the
Student t-test to  estimate the  significance  of  differ-
ences (at p < 0.05). Correlations were determined by
linear regression analysis.
Results
The viability of cells tested at the end of the cultures
remained,  in  general,  at  the  level  of  80%  of  initial
number of cells set in the culture. In several cases of
lower  cell  viability  obserbed  at  the  end  of  the
cultures, the results were dicounted.
Table  1  demonstrates  results  of  representative
experiments  in  which  PBMC  microcultures  were
routinely  stimulated  with  PHA  at  0h,  left  without
stimulation  for  24h,  and  then  treated  with  the
mitogen or stimulated with PHA at 24h after partial
exchange  of  culture  medium. The  cells  responded
well  to  routine  mitogenic  stimulation  (range  of
response, 31.2 ± 4.1 ´ 103 to 71.3 ± 5.3 ´ 103 dpm),
but did not respond at all if they were stimulated with
PHA  at  24h  (3HTdR  incorporation  remained  at
the level of spontaneous incorporation observed in
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Table 1. Effects of partial exchange of medium in cultures stimulated with PHA at 24h of incubation
[
3H]-Thymidine incorporation into triplicate cultures (dpm ´ 10
3 ± SD)





















1 1.8 ± 0.10 42.6 ± 5.2 2.2 ± 0.6 12.2 ± 1.1 23.7 6.8
2 1.0 ± 0.08 31.2 ± 4.1 1.6 ± 0.1 16.2 ± 2.2 31.2 16.2
3 1.6 ± 0.05 58.8 ± 1.7 2.4 ± 0.2 20.6 ± 0.7 36.7 12.9
4 1.7 ± 0.10 71.3 ± 5.3 1.9 ± 0.3 8.4 ± 1.3 41.9 4.9
a At 24h, half the volume (0.1ml) of cell-free medium was removed and replaced with 0.1ml of CFM from PHA-stimulated culture.
b PHA index = (dpm in cultures stimulated with PHA at 0h) / (dpm in non-stimulated cultures).
c LM index = (dpm in cultures stimulated with PHA at 24h after the change of medium) / (dpm in non-stimulated cultures).
Table 2. Cultures preincubated for 24h and then stimulated with PHA: effects of partial absorption of culture medium (cell-free
medium (CFM)) with autologous lymphocytes
Cultures Control Procedure Experimental Procedure
0h U U U – U U U U U U –
24h U U U U U U U U U Half the volume of CFM (6 ´ 0.1ml) removed,
absorbed for 30min with 10
6 lymphocytes and
volumes of 0.1ml of CFM returned to the first
triplicate of cultures
)
( + PHA )
(
48h U U U ( + 3HTdR ) U U U – – – –
72h 1607 ± 144 dpm measurement
of 3HTdR
incorporation
4188 ± 16 dpm Statistical significance (p < 0.01)control  cultures). After  partial  exchange  of  culture
medium, the cells regained some ability to respond to
delayed stimulation with PHA: their responses calcu-
lated as LM indices were considerably lower than, and
did  not  relate  directly  to,  the  values  of  ‘normal’
response  to  PHA. The  other  way  of  rendering  the
unresponsive cells responsive to delayed stimulation
was to treat part of the culture medium (0.1ml from
each  of  the  cultures)  to  short  absorption  with
autologous  lymphocytes  and  then  return  it  to  the
original  microculture  before  stimulation  with  PHA.
The results of respective experiments are presented
in Table 2.
To determine the influence of chosen monokines
on the response of PBMC to delayed stimulation with
PHA,  a  series  of  experiments  were  performed  in
which cultures were supplemented with exogenous
IL-1b (20ng/ml) or IL-1ra (20ng/ml). The results are
presented in Table 3. As a mean value of 8.2 ± 2.5 of
the  LM  index  was  found  in  the  PBMC  cultures  of
healthy donors (see Table 5), the breakeven point 6.0
has  been  arbitrarily  chosen  for  further  discerning
between the low and the high LM values observed in
PBMC  cultures.  The  supplementation  with  IL-1b
resulted in considerable increases in the LM values of
cultures demonstrating a low level of reactivity (LM
index < 6.0 in control cultures) but did not change
the LM values in cultures expressing higher levels of
reactivity  (LM  index  >  6.0  in  control  cultures).
Opposing effects were observed in cultures supple-
mented with IL-1ra. Low LM values did not change,
but  high  LM  values  decreased  significantly.  The
existence of this competitive influence of IL-1ra and
IL-1b on  the  response  of  lymphocytes  to  delayed
stimulation with PHA, as expressed by LM values, has
been confirmed in experiments involving application
of neutralising anti-IL-1ra antibodies. Addition of anti-
IL-1ra antibody in a dose of 5 m g/ml into the micro-
cultures resulted, on average, in a twofold increase in
the LM index. The results of respective experiments
are presented in Table 4.
In  the  next  series  of  experiments  (Fig.  1),  per-
formed on PBMC derived from 10 patients suffering
from acute tonsillitis, the LM values and IL-1ra/IL-1b
concentration  ratios  were  estimated  for  control
microcultures and for microcultures treated with pure
substance cefaclor (40 m g/ml). In the cultures treated
with cefaclor, significant reductions in the values of
the LM index were observed (mean values, 26.8 ± 8.3
for control cultures and 11.3 ± 3.2 for cefaclor treated
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Table 3. Cultures preincubated for 24h and then stimulated with PHA: influence of supplementation with IL-1b (20ng/ml) or IL-
1ra (20ng/ml) on the values of LM indices
Experiments in which a high response
(LM index > 6.0) has been observed
IL-1b IL-1ra
Experiments in which a low response
(LM index < 6.0) has been observed
IL-1b IL-1ra
0.92 0.77 1.53 0.96
1.35 0.63 2.23 1.19
1.03 0.79 1.53 1.09
1.05 0.51 3.68 1.18
0.93 0.70 2.18 1.03
1.20 0.61 2.03 1.01
0.98 0.35 3.04 0.99
¯ x = 1.06 ± 0.16 ¯ x = 0.62 ± 0.16 ¯ x = 2.32 ± 0.79 ¯ x = 1.06 ± 0.08
Data are the ratio of [3H]-thymidine incorporation into the treated with monokine cultures and non-treated cultures
Table 4. Influence of anti-IL-1ra antibodies on [
3H]-thymidine incorporation (dpm ´ 10










1 – 0.9 ± 0.01 15.5 ± 0.5 17.2
+ 1.7 ± 0.20 59.6 ± 4.4 35.1
2 – 1.1 ± 0.20 18.2 ± 0.6 16.5
+ 1.0 ± 0.06 35.2 ± 2.8 35.2
3 – 1.0 ± 0.07 8.1 ± 1.5 8.1
+ 1.2 ± 0.10 14.5 ± 1.8 12.1
4 – 1.1 ± 0.10 4.3 ± 0.4 3.9
+ 1.1 ± 0.20 7.2 ± 0.6 6.5
a At 24h of incubation, half the volume (0.1ml) of cell free medium was removed and replaced with 0.1ml of fresh medium with PHA.cultures;  p <  0.01),  and  these  changes  were  well
correlated (r2 = 0.81) with the changes of the values
of IL-1ra/IL-1b concentration ratio (mean values, 7.5 ±
2.3 for control cultures and 35.1 ± 16.9 for cultures
treated with cefaclor; p < 0.01).
The results presented in Table 5 compare the LM
values, the IL-1b and IL-1ra concentrations, and the IL-
1ra/IL-1b concentration  ratios  observed  in  micro-
cultures  of  PBMC  from  healthy  donors  and  from
patients with acute inflammation of the upper respira-
tory tract. The mean value of LM indices observed in
the group of patients (18.4  ± 5.8)  was significantly
higher  than  the  respective  value  in  the  group  of
healthy donors (8.2 ± 2.5). The mean value of the IL-
1b concentration  in  the  patients’  PBMC  cultures
(633.8  ± 244.5pg/ml) was also considerably higher
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FIG.  1.  Values  of  LM  indices  depend  on  the  ratio  of  IL-1ra/IL-1b concentration  in  peripheral  blood  mononuclear  cell
microcultures treated with cefaclor.
Table 5. LM values, IL-1b , IL-1ra concentrations (pg/ml) and IL-1ra/IL-1b concentration ratios in microcultures of peripheral
blood mononuclear cells (PBMC) from healthy donors and from patients with acute infections of the upper respiratory tract
PBMC microcultures from: Mean value ± SD
LM index IL-1b IL-1ra IL-1ra/IL-1b
Healthy donors (n = 20) 8.2 ± 2.5 170 ± 90 1900 ± 810 11.1 ± 7.5
Patients (n = 20) 18.4 ± 5.8 630 ± 240 2560 ± 915 4.0 ± 1.8
Statistical significance, p < 0.01 < 0.01 NS < 0.05than in cultures of healthy donors’ PBMC (167.75 ±
89.5pg/ml). The IL-1ra concentrations were high in
healthy donors’ (1867.25 ± 806.5pg/ml) as well as in
patients’ PBMC cultures (2559.31 ± 914.7pg/ml), and
did not represent statistically significant differences.
The  calculated IL-1ra/IL-1b concentration ratio  was
significantly higher for healthy donors (11.13 ± 7.5)
than for the patients (4.03 ± 1.76).
Discussion
Since Mitchison’s classic ‘three mouse experiment’12
demonstrating T-cell, B-cell and macrophage coopera-
tion  in  development  of  the  immune  response,  the
immunogenic  role of monocytes and other antigen
presenting cells  (APC) has been extensively  investi-
gated and  become  well  recognised.1,2,13–14 Antigen
presentation is an immunogenic as a complex with
self-histocompatibility molecules (MHC class II anti-
gens).  This  permits  the  APC  (monocytes,  macro-
phages  or  dendrytic  cells)  to  recruit  from  the
polyclonal  pool  of  immunocompetent  T  cells  the
helper-inducer  TCD4+  lymphocyte  representing  a
clonal  specificity  complementary  to  the  presented
antigen. Further development of a specific immune
response greatly depends on the quality and quantity
of  additional  co-stimulatory  signals  from  the  APC
whereby they modulate the behaviour of responding
cells,16–18
In the large repertoire of APC products, there are
two possessing distinguishable potential to regulate
the proliferative phase of the T-lymphocyte response.
One is IL-1, already known for its multiple immuno-
enhancing  and  pro-inflammatory effects,1,2 and the
other  (the  more  recently  recognised  IL-1ra)  is  a
natural inhibitor of the former.18–20
The population of PBMC contains both APC (mono-
cytes)  and  T  lymphocytes  in  quantities  and  with
typical  functional  properties  characteristic  for  the
donor. The inactive lymphocytes remaining at the Go
stage of their cell cycle do not spontaneously produce
any cytokine until reception of mitogenic stimulation.
The  monocytes,  however,  produce  in  vitro the
monokine repertoire representative of their in vivo
activity.8 Thus, assessment of the level of proliferative
response of T cells co-cultured with monocytes and
exposed  to  their  influence  prior  the  mitogenic
stimulation should supposedly indicate which of the
competitive  monokines,  IL-1ra  or  IL-1,  is  currently
gaining the functional preponderance over the com-
petitor. This, in turn,  may  serve to characterise the
actual functional state of the monocytes in question,
and,  in  so  doing  suggests  a  role  for  the  use  of T
lymphocytes as indicator cells.
The  results  of  our  experiments  on  PBMC  have
confirmed  the  dependence  of  the  T-lymphocyte
response  to  delayed  stimulation  with  PHA  on  the
proportion  of  IL-1ra  and  IL-1b produced  by  the
monocytes into the culture medium before mitogenic
stimulation.  Non-responding  T  cells  appeared  to
regain  their  proliferative  ability  if  the  inhibitory
influences of IL-1ra were reduced by partial exchange
of  the  medium,  or  by  exposure  of  the  medium  to
autologous  lymphoctes,  or  by  the  addition  to  the
culture of anti-IL-1ra antibodies.
The level of regained reactivity, given as the LM value
that did not relate to the level of ‘normal’ response to
PHA, also did not correlate directly with the concentra-
tion of IL-1b or IL-1ra found in the culture medium, but
it did appear to correlate with the changes of IL-1ra/IL-
1b concentration ratio. The  cultures  supplemented
with the exogenous IL-1b demonstrated increased LM
values if control LM values were low (< 6.0) but not if
they  were  high  (>  6.0).  Conversely,  addition  of
exogenous IL-1ra decreased the high LM values but did
not change the low LM values. The results seem to
reflect the effects of competition between the added
and endogenous IL-1ra and IL-1b for  access to IL-1
receptors on target cells.
The next series of experiments were performed to
evaluate the possibility of application of the LM index
assessments  for  clinical  diagnostic  purposes.  The
cultures  of  PBMC  from  10  patients  suffering  from
acute tonsilitis were set-up and tested for this, as well
as for the values of  IL-1ra/IL-1b concentration ratio
under  in  vitro influence  of  cefaclor,  the  antibiotic
usually  administered  in  vivo for  treatment  of  the
disease.  In  vitro addition  of  cefaclor  resulted  in
significant increase of IL-1ra/IL-1b concentration ratio
(from  7.5  ±  2.3  to  35.1  ±  16.9)  and  in  correlated
decrease of LM values (from 26.8 ± 8.3 to 11.3 ± 3.2).
The  close  correlation  of  the  changes  in  the  two
parameters suggests that assessment of the LM index
in  PBMC  cultures  may  serve  as  a  suitable  and
inexpensive  test  for  evaluation  of  the  monocyte
immunogenic  activity. The  suggestion  has  received
further confirmation from the results of assessments
of  LM  values  and  IL-1ra/IL-1b concentration  ratios
performed on cultures of PBMC from healthy donors
(n = 20) and from patients with acute or exacerbated
upper respiratory tract infections (n = 20). The results
presented in Table 5 show that the mean LM index
value  representative  for  the  healthy  donor’s  group
(8.2 ± 2.5) is significantly lower than the respective
value  observed in  the  patients’  group  (18.4  ± 5.8)
and, reciprocally, the IL-1ra/IL-1b concentration ratio
is considerably higher in the healthy donors’ PBMC
cultures (11.13  ± 5.51)  than in  the patients’ PBMC
cultures (4.03 ± 1.76). In the patients’ PBMC cultures,
both the IL-1b and IL-1ra concentrations were higher
than in the healthy donors’ cultures, but a relatively
high  IL-1b concentration  appeared  to  be  mainly
responsible for the observed diminution in IL-1ra/IL-
1b ratio.
In conclusion, the proposed modification of proce-
dure  based  on  delayed  stimulation  with  PHA  and
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in  human  PBMC  microcultures  seems  to  offer  a
relatively  simple  and  inexpensive  method  for  con-
veniently assessing monocyte immunogenic activity.
The  method  of  LM  assay  would  appear  to  be
prospectively  useful  for  diagnostic  evaluation  of
monocyte  influence  on  the  development  of  tissue
inflammatory  processes  and  on  the  lymphocyte
proliferative response. Supposedly, the LM assay may
also  find  application  in  clinical  monitoring  of  the
potency of different immunotropic drugs for influenc-
ing the monocyte functional state.
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